# Relationship Between Glycemic Control and Irisin in Type 2 Diabetic Patients With Sarcopenic or Non-sarcopenic Obesity

> **NCT05908812** · — · RECRUITING · sponsor: **Azienda Ospedaliero-Universitaria Consorziale Policlinico di Bari** · enrollment: 120 (estimated)

## Conditions studied

- Sarcopenia
- Obesity
- Diabetes Mellitus, Type 2

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT05908812
- **Lead sponsor:** Azienda Ospedaliero-Universitaria Consorziale Policlinico di Bari
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2023-02-01
- **Primary completion:** 2025-01-31
- **Final completion:** 2025-01-31
- **Target enrollment:** 120 (ESTIMATED)
- **Last updated:** 2024-08-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05908812

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05908812, "Relationship Between Glycemic Control and Irisin in Type 2 Diabetic Patients With Sarcopenic or Non-sarcopenic Obesity". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT05908812. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*